Pacira Pharmaceuticals (82P) Q2 2025 Earnings Report
DE:82P Q2 2025 EPS Results
- Actual EPS
- EUR 0.66
- Consensus EPS
- EUR 0.63
- Beat/Miss
- Beat by +EUR 0.03
- One Year Ago EPS
- EUR 0.80
DE:82P Q2 2025 Revenue Results
- Actual Revenue
- EUR 161.92M
- Expected Revenue
- EUR 163.69M
- Beat/Miss
- Missed by -EUR 1.76M
- YoY Revenue Growth
- +1.73%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/05/2025
- Time
- After Close
- Conference Call
- Tuesday, August 5, 2025
DE:82P Upcoming Earnings
Pacira Pharmaceuticals's next earnings date is estimated for March 4, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
DE:82P Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:82P Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 04, 2027 | 2026 (Q4) | ―- | 0.51 | ― | ― |
| Oct 29, 2026 | 2026 (Q3) | 0.65- | 0.63 | ― | |
| Aug 04, 2026 | 2026 (Q2) | 0.580.65 | 0.66 | -1.35% (-0.01) | |
| Apr 30, 2026 | 2026 (Q1) | 0.490.54 | 0.55 | -3.23% (-0.02) | |
| Feb 26, 2026 | 2025 (Q4) | 0.810.51 | 0.81 | -37.36% (-0.30) | |
| Nov 06, 2025 | 2025 (Q3) | 0.610.63 | 0.71 | -11.39% (-0.08) | |
| Aug 05, 2025 | 2025 (Q2) | 0.630.66 | 0.8 | -16.85% (-0.13) | |
| May 08, 2025 | 2025 (Q1) | 0.530.55 | 0.55 | 0.00% (+0.00) | |
| Feb 27, 2025 | 2024 (Q4) | 0.750.81 | 0.8 | 2.25% (+0.02) | |
| Nov 06, 2024 | 2024 (Q3) | 0.630.71 | 0.64 | 9.72% (+0.06) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
